Arcturus Therapeutics Holdings Inc. - 10-Q Filing
Arcturus Therapeutics Holdings Inc. filed its quarterly report for the period ended March 31, 2026, providing unaudited financial statements and operational updates. The report includes details on collaboration revenue from agreements such as the CSL Seqirus collaboration and grants from entities like the Gates Foundation and Biomedical Advanced Research and Development Authority. The company also outlines its financial position, including research and development expenses, general and administrative expenses, and cash flow activities.
Tickers: $ARCT